AXGN

SEC source: 0000805928-25-000167 · wk-form4_1765405262.xml · nonDerivative · entry 1

DALE MICHAEL D · CIK 0001172346 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,537

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units on December 4, 2025. This sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold on December 9, 2025, in multiple transactions at $31.208 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000166 · wk-form4_1765405243.xml · derivative · entry 6

TYNDALL JOSEPH A. · CIK 0001955281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,311

Underlying: Common Stock · 10,860 shares

Expires 2032-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 13, 2023.

SEC source: 0000805928-25-000166 · wk-form4_1765405243.xml · derivative · entry 5

TYNDALL JOSEPH A. · CIK 0001955281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,248 shares

Expires 2034-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Non-qualified stock option portion of the 2024 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant vested on June 6, 2025, the one-year anniversary of the grant date.

SEC source: 0000805928-25-000166 · wk-form4_1765405243.xml · nonDerivative · entry 4

TYNDALL JOSEPH A. · CIK 0001955281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.485 to $31.305 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000166 · wk-form4_1765405243.xml · nonDerivative · entry 3

TYNDALL JOSEPH A. · CIK 0001955281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,860

F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.485 to $31.305 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000166 · wk-form4_1765405243.xml · nonDerivative · entry 2

TYNDALL JOSEPH A. · CIK 0001955281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000166 · wk-form4_1765405243.xml · nonDerivative · entry 1

TYNDALL JOSEPH A. · CIK 0001955281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,248

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000165 · wk-form4_1765405224.xml · nonDerivative · entry 1

DeVinney Erick Wayne · CIK 0001595972 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,132

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units on December 4, 2025. This sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold on December 9, 2025, in multiple transactions at $31.208 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000164 · wk-form4_1765405208.xml · nonDerivative · entry 1

Kemp Jens · CIK 0002007485 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,030

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units on December 4, 2025. This sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold on December 9, 2025, in multiple transactions at $31.208 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000162 · wk-form4_1765405180.xml · nonDerivative · entry 1

Began Marc A · CIK 0001821352 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,507

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units on December 4, 2025. This sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold on December 9, 2025 in multiple transactions at $31.208 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000161 · wk-form4_1765405158.xml · nonDerivative · entry 1

THOMAS PAUL · CIK 0001166776 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,528

F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.56 to $29.70 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001410781-25-000004 · wk-form4_1765405138.xml · derivative · entry 8

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,545 shares

Expires 2033-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Non-qualified stock option portion of the 2023 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant became fully vested on September 1, 2024, the one-year anniversary of the grant date.

SEC source: 0001410781-25-000004 · wk-form4_1765405138.xml · nonDerivative · entry 6

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F3 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.90 to $30.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001410781-25-000004 · wk-form4_1765405138.xml · nonDerivative · entry 5

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,141

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.02 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001410781-25-000004 · wk-form4_1765405138.xml · nonDerivative · entry 4

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,686

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001410781-25-000004 · wk-form4_1765405138.xml · derivative · entry 7

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,545

Underlying: Common Stock · 11,891 shares

Expires 2033-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Non-qualified stock option portion of the 2023 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant became fully vested on September 1, 2024, the one-year anniversary of the grant date.

SEC source: 0001410781-25-000004 · wk-form4_1765405138.xml · nonDerivative · entry 3

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,141

F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001410781-25-000004 · wk-form4_1765405138.xml · nonDerivative · entry 2

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001410781-25-000004 · wk-form4_1765405138.xml · nonDerivative · entry 1

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,141

F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000805928-25-000160 · wk-form4_1765405121.xml · derivative · entry 6

Hartley Lindsey Marie · CIK 0002068693 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 5,000 shares

Expires 2032-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares have vested or will vest each 6 months thereafter.

SEC source: 0000805928-25-000160 · wk-form4_1765405121.xml · derivative · entry 5

Hartley Lindsey Marie · CIK 0002068693 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2031-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on November 1, 2025 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on November 1, 2023 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

SEC source: 0000805928-25-000160 · wk-form4_1765405121.xml · nonDerivative · entry 4

Hartley Lindsey Marie · CIK 0002068693 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,376

SEC source: 0000805928-25-000160 · wk-form4_1765405121.xml · nonDerivative · entry 3

Hartley Lindsey Marie · CIK 0002068693 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,230

SEC source: 0000805928-25-000160 · wk-form4_1765405121.xml · nonDerivative · entry 2

Hartley Lindsey Marie · CIK 0002068693 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000160 · wk-form4_1765405121.xml · nonDerivative · entry 1

Hartley Lindsey Marie · CIK 0002068693 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000151 · wk-form4_1764971775.xml · nonDerivative · entry 1

Began Marc A · CIK 0001821352 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,785

F1 · shares: This reflects the number of shares issued upon the attainment of certain performance criteria.

SEC source: 0000805928-25-000150 · wk-form4_1764971712.xml · nonDerivative · entry 1

DeVinney Erick Wayne · CIK 0001595972 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,649

F1 · shares: This reflects the number of shares issued upon the attainment of certain performance criteria.

SEC source: 0000805928-25-000149 · wk-form4_1764971601.xml · nonDerivative · entry 1

Kemp Jens · CIK 0002007485 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,186

F1 · shares: This reflects the number of shares issued upon the attainment of certain performance criteria.

SEC source: 0000805928-25-000145 · wk-form4_1764968812.xml · nonDerivative · entry 1

DALE MICHAEL D · CIK 0001172346 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: This reflects the number of shares that vested as of December 4, 2025 upon the attainment of certain performance criteria.

SEC source: 0000805928-25-000136 · wk-form4_1763069511.xml · derivative · entry 6

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,591 shares

Expires 2032-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.

SEC source: 0000805928-25-000136 · wk-form4_1763069511.xml · nonDerivative · entry 4

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F2 · price: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.13 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000805928-25-000136 · wk-form4_1763069511.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000136 · wk-form4_1763069511.xml · derivative · entry 5

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,591

Underlying: Common Stock · 19,227 shares

Expires 2032-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.

SEC source: 0000805928-25-000136 · wk-form4_1763069511.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F1 · price: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.10 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000805928-25-000136 · wk-form4_1763069511.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,327

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000134 · wk-form4_1762552351.xml · derivative · entry 6

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,818

Underlying: Common Stock · 5,347 shares

Expires 2032-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.

SEC source: 0000805928-25-000134 · wk-form4_1762552351.xml · nonDerivative · entry 4

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F2 · price: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.06 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000805928-25-000134 · wk-form4_1762552351.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,447

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000134 · wk-form4_1762552351.xml · derivative · entry 5

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,165

Underlying: Common Stock · 11,431 shares

Expires 2032-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.

SEC source: 0000805928-25-000134 · wk-form4_1762552351.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F1 · price: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000805928-25-000134 · wk-form4_1762552351.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · derivative · entry 9

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,248 shares

Expires 2034-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This grant vested on the first anniversary of the date of the grant, June 6, 2024.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · nonDerivative · entry 6

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F2 · price: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · nonDerivative · entry 5

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · derivative · entry 8

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,596

Underlying: Common Stock · 19,799 shares

Expires 2032-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · derivative · entry 7

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,436 shares

Expires 2033-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This grant vested on the first anniversary of the date of the grant, September 1, 2023.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · nonDerivative · entry 4

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F2 · price: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,899

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F1 · price: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.50 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000805928-25-000132 · wk-form4_1761941351.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,536

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.